Related content

Δ32 Mutation of the Chemokine-Receptor 5 Gene in Inflammatory Bowel Disease

By Martin K.   Heinzlmann M.   Borchers R.   Mack M.   Loeschke K.   Folwaczny C.  

Clinical Immunology, Vol. 98, Iss. 1, 2001-01 ,pp. : 18-22

Academic Press

Access to resources Recommend Favorite

Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis

By Field J.   Marshall A.C.J.   J. Hertzog P.   Wells T.N.   Alderuccio F.   Toh B.-H.  

Clinical Immunology, Vol. 109, Iss. 2, 2003-11 ,pp. : 238-247

Elsevier

Access to resources Recommend Favorite

Peptide T Blocks GP120/CCR5 Chemokine Receptor-Mediated Chemotaxis

By Redwine L.S.   Pert C.B.   Rone J.D.   Nixon R.   vance M.   Sandler B.   Lumpkin M.D.   Dieter D.J.   Ruff M.R.  

Clinical Immunology, Vol. 93, Iss. 2, 1999-11 ,pp. : 124-131

Academic Press

Access to resources Recommend Favorite

Desensitization of Chemokine Receptor CCR5 in Dendritic Cells at the Early Stage of Differentiation by Activation of Formyl Peptide Receptors

By Le Y.   Wetzel M.A.   Shen W.   Gong W.   Rogers T.J.   Henderson E.E.   Wang J.M.  

Clinical Immunology, Vol. 99, Iss. 3, 2001-06 ,pp. : 365-372

Academic Press

Access to resources Recommend Favorite

The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis

By Tokuyama Hirotake  

International Immunology, Vol. 17, Iss. 8, 2005-08 ,pp. : 1023-1034

Oxford University Press

Access to resources Recommend Favorite